SELLAS Life Sciences Group Inc (SLS)
0.968
+0.06
(+6.48%)
USD |
NASDAQ |
Dec 24, 11:44
SELLAS Life Sciences Group Cash from Operations (Quarterly): -7.806M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Microbot Medical Inc | -2.759M |
| Alaunos Therapeutics Inc | -0.781M |
| Galectin Therapeutics Inc | -8.538M |
| Oragenics Inc | -1.970M |
| Anavex Life Sciences Corp | -5.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 19.69M |
| Free Cash Flow | -33.07M |
| Free Cash Flow Per Share (Quarterly) | -0.1144 |
| Free Cash Flow Yield | -67.83% |